Page 8 - Robert Weinstein News Today

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative...

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX), a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative...

/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for...

Chicago Tribune (TNS)

The Weinstein Co.'s former co-chair Robert Weinstein on Wednesday said Spyglass Entertainment Co.'s attempts to shoot down his claim to a cut of proceeds from the film "Scream 4" were hearsay, denying arguments that his rights ended with the entertainment company's Delaware Chapter 11 sale.

ADVERTISEMENT Spyglass Fires Back At Weinstein Brothers Demand For Pay Law360 (July 23, 2021, 8:37 PM EDT) -- Spyglass Entertainment told a Delaware bankruptcy judge on Friday that it didnt owe former Weinstein Co. co-chair Robert Weinstein any film profit-sharing payments after it bought the companys assets out of Chapter 11, saying it bought the assets to strip them of any association with the company or its founders. In an objection to Robert Weinsteins motion for the payment of $2.3 millio...

There’s astrology for relationships, pets, political movements and, yes, bitcoin.

Synaptogenix Announces Phase 2b NIH Sponsored Alzheimers Disease Trial Update - Data Safety Monitoring Board confirms Bryostatin-1 Safety News provided by Share this article Share this article NEW YORK, June 9, 2021 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced an update on its ongoing National Institutes of Health ("NIH") sponsored Phase 2b clinical trial of Bryostatin-1...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Synaptogenix to Present at Sachs 4th Annual Neuroscience Innovation Forum April 26, 2021 GMT NEW YORK, April 26, 2021 /PRNewswire/ -- Synaptogenix, Inc. (OTC: SNPX) (“Synaptogenix” or the “Company”), an emerging biopharmaceutical company focused on developing therapies for neurodegenerative diseases, today announced that Dr. Daniel Alkon, the Company’s President and Chief Scientific Officer, wi...

Kyuquot, buried along the inside much of the way in the $40,000 Bobby Weiss Series Championship for three-year-old males Saturday afternoon at The Downs at Mohegan Sun Pocono, was angled to the far outside the first part of the stretch by driver Tyler Buter, then got up on the line for a 70-1 upset in 1:52.2, while heavy favourite One Eight Hundred was trapped behind a horse and got shuffled out of contention. One Eight Hundred was sent right to the lead and took the field to the quarter in :26...